Recurrent Platinum Resistant Ovarian Cancer
Also known as: Platinum-resistant Recurrent Ovarian Cancer / Recurrent, Platinum-resistant Ovarian Cancer / Recurrent Platinum-resistant Ovarian Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14873 | Enadenotucirev | 1 | Completed | 1 |
DB11648 | Afuresertib | 1 / 2 | Completed | 1 |
DB00958 | Carboplatin | 1 / 2 | Completed | 1 |
DB01229 | Paclitaxel | 1 / 2 | Completed | 1 |
DB00062 | Albumin human | 2 | Recruiting | 1 |
DB11885 | Anlotinib | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB14776 | Camrelizumab | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB12033 | Cediranib | 2 | Completed | 1 |
DB04849 | Cediranib | 2 | Recruiting | 1 |
DB01262 | Decitabine | 2 | Recruiting | 1 |
DB01248 | Docetaxel | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB11714 | Durvalumab | 2 | Recruiting | 1 |
DB00441 | Gemcitabine | 2 | Recruiting | 1 |
DB01006 | Letrozole | 2 | Recruiting | 1 |
DB14933 | Nicotinamide riboside | 2 | Terminated | 1 |
DB09074 | Olaparib | 2 | Completed | 1 |
DB09074 | Olaparib | 2 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 2 |
DB14765 | Rivoceranib | 2 | Active Not Recruiting | 1 |
DB14765 | Rivoceranib | 2 | Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Recruiting | 1 |
DB17473 | APL-502 | 3 | Recruiting | 1 |
DB11885 | Anlotinib | 3 | Recruiting | 1 |
DB15175 | Ofranergene obadenovec | 3 | Completed | 1 |
DB01229 | Paclitaxel | 3 | Completed | 1 |
DB01229 | Paclitaxel | 3 | Recruiting | 1 |